Trametinib (Mekinist) and cobimetinib (Cotellic) are new targeted treatments for patients with unresectable or metastatic melanoma who have a BRAF V600 mutation
The gold standard of treatment for lentigo maligna is surgery, but this can result in significant scarring
Patients with advanced melanoma can now benefit from a new class of drugs targeting the immune system, with the launch of nivolumab (Opdivo) and pembrolizumab (Keytruda)
Register or Subscribe to MIMSGPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.
MIMS bulletinsNews and updates straight to your inbox.
Prescribing Update: Fortnightly news bulletin
Alert: Urgent prescribing updates
Spotlight: Disease-themed monthly round-up
Read the latest issue online exclusively on MIMS Learning.
Especially created for prescribing influencers.